In patients with diabetes, sustained use of GLP-1 receptor agonists is associated with a modestly higher risk for new-onset ...
With buzzy medications like Ozempic and Mounjaro making headlines for blood sugar management, it’s easy to forget that some medications have been helping patients with type 2 diabetes for decades.
Verywell Health on MSN
Mounjaro vs. Trulicity: How do they compare for type 2 diabetes?
Medically reviewed by Mary Choy, PharmD Key Takeaways Mounjaro often leads to greater reductions in hemoglobin A1C and weight compared to similar medications.Trulicity can help reduce major ...
For Kelli Coviello, injections of Wegovy didn’t just satiate her appetite and help her lose weight. They lowered her blood pressure, improved her mood, and helped her think clearly. Coviello, a ...
Share on Pinterest A new study found that certain diabetes medications could help lower the risk of neurodegenerative diseases. FG Trade/Getty Images A team of scientists in Korea recently ...
A recent study from the Yale School of Public Health and other institutions has found that the diabetes drug rosiglitazone ...
BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. The biotech linked its challenger to bigger reductions in blood sugar than Novo Nordisk’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results